Xinru Chen, Caicun Zhou, Li Zeng, Ya Geng, Yao Liu. "First-in-human phase I, open-label, multicenter study of HJ-004, a novel EGFR-PROTAC degrader, in patients with advanced
                    <i>EGFR</i>
                    -mutated non–small cell lung cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps8678